---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-24-000716"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2024-04-30T23:59:59+00:00"
generated_at: "2026-06-03T04:21:17.933196+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# RenovaroCube unveils Flamingo AI model for early multi-cancer detection via fragmentomics

## Summary
- Flamingo uses ultra-low pass WGS of cfDNA; requires as few as 200,000 fragments per sample.
- Model integrates fragment lengths, sequence motifs, and neural network to distinguish cancer vs. healthy.
- Part of The Cube platform, combining multi-omic data for comprehensive early detection and monitoring.
- RenovaroCube is wholly owned by Renovaro (Nasdaq: RENB); Cyclomics acquisition previously announced.

## SEC filing metadata
- accession: 0001731122-24-000716
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2024-04-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000716/0001731122-24-000716-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000716/e5636_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-24-000716
- JSON: https://secwatch.observer/filing/0001731122-24-000716.json
- Plain text: https://secwatch.observer/filing/0001731122-24-000716.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.